Emergency radium RA 223 dichloride - xofigo
Ended Awarded Last action
- Contract number
- 36C24824N0873
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $101,006
Award facts
- Contract value 100% obligated
- $101,005.97 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,468 | |
| Original award | $115,474 |
About this award
This federal contract award to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG, is for the delivery of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical used to treat prostate cancer. The $101,005.97 firm fixed-price delivery order was issued by the U.S. Department of Veterans Affairs (VA), under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. This multiple-award schedule contract has a potential value of $840 million and allows various federal agencies to order a wide range of pharmaceutical products. The contract has no set-aside designation, reflecting Bayer's status as a large, foreign-owned business. Bayer Healthcare Pharmaceuticals Inc. also holds an $18.2 million Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical for supplying pharmaceuticals and medical supplies. These contract vehicles enable Bayer to provide critical medications to support healthcare programs for veterans, active-duty military personnel, and federal medical facilities.
Quick answers
Who was awarded contract 36C24824N0873?
36C24824N0873 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on June 20, 2024.
How much is contract 36C24824N0873 worth?
The government has obligated $101,006 on 36C24824N0873.
Is contract 36C24824N0873 an order under another contract?
Yes. 36C24824N0873 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24824N0873 competed?
The extent of competition for 36C24824N0873 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award